L&T and Piramal Pharma Q2 results lift shares as margin falls and profit returns

Generic user silhouette icon Varda Khade - 0 min read

Last Updated: 28th October 2026 - 02:25 pm

On 28 October 2026, Larsen and Toubro shares rose 5% after its Q2 consolidated profit increased 33% to ₹5,202 crore, while Piramal Pharma shares rose 12% as its consolidated profit turned positive at ₹5.58 crore. L&T reported higher revenue and order inflow, but its EBITDA margin declined. Piramal Pharma's revenue also increased during the quarter.

L&T reports ₹1.47 lakh crore order inflow as margin falls to 8.7%

L&T’s consolidated profit has climbed to ₹5,202 crore in the quarter under review from ₹3,926 crore in the corresponding quarter last year. In terms of revenue, L&T reported ₹78,750 crore in the quarter, a rise of 16% as per a company statement.

L&T also disclosed an increase in order inflow during the quarter. Its EBITDA margin was below the earlier 10% level, the company reported.

Piramal Pharma returns to profit at ₹5.58 crore

Piramal Pharma’s consolidated numbers have moved from a loss of ₹99.2 crore in the year ago quarter to a profit in the current quarter. Revenues have gone up by 28% to ₹2,617.1 crore in the quarter under review.

L&T shares rise 5% at 9:46 AM IST

Stock-market data recorded the L&T share move at 9:46 AM IST on 28 October 2026.

Piramal Pharma shares rise 12% at 9:46 AM IST

Stock-market data recorded the Piramal Pharma share move at 9:46 AM IST on 28 October 2026.

FREE Trading & Demat Account
Open FREE Demat Account with endless opportunities.
  • Flat ₹20 Brokerage
  • Next-gen Trading
  • Advanced Charting
  • Actionable Ideas
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
OR
hero_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Aticles to read next